Anders Buur

999 total citations
36 papers, 829 citations indexed

About

Anders Buur is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Anders Buur has authored 36 papers receiving a total of 829 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Oncology and 8 papers in Organic Chemistry. Recurrent topics in Anders Buur's work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (7 papers) and Chemical Synthesis and Analysis (5 papers). Anders Buur is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Cancer Treatment and Pharmacology (7 papers) and Chemical Synthesis and Analysis (5 papers). Anders Buur collaborates with scholars based in Denmark, United States and Japan. Anders Buur's co-authors include Henning Bundgaard, Vincent H.L. Lee, Shih‐Chieh Chang, Erik Falch, H.V. BRØNDSTED, Lars Hovgaard, Claus Larsen, Hitoshi Sasaki, Du‐Shieng Chien and Judi Møss and has published in prestigious journals such as Journal of Controlled Release, Journal of Medicinal Chemistry and International Journal of Pharmaceutics.

In The Last Decade

Anders Buur

36 papers receiving 796 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anders Buur Denmark 19 286 257 224 179 107 36 829
Staffan Tavelin Sweden 13 293 1.0× 383 1.5× 345 1.5× 60 0.3× 127 1.2× 14 1.0k
Balvinder S. Vig United States 18 464 1.6× 141 0.5× 329 1.5× 150 0.8× 47 0.4× 26 973
I Hayakawa Japan 25 650 2.3× 149 0.6× 96 0.4× 547 3.1× 111 1.0× 77 1.7k
Per Artursson Sweden 6 402 1.4× 412 1.6× 448 2.0× 65 0.4× 95 0.9× 8 1.2k
Sheeba Varghese Gupta United States 12 187 0.7× 120 0.5× 92 0.4× 157 0.9× 38 0.4× 23 654
Tim Quach Australia 17 234 0.8× 153 0.6× 128 0.6× 203 1.1× 35 0.3× 29 757
Harvey Schwam United States 21 730 2.6× 52 0.2× 42 0.2× 478 2.7× 62 0.6× 31 1.2k
Doo‐Man Oh United States 10 144 0.5× 301 1.2× 188 0.8× 56 0.3× 94 0.9× 13 645
Thomas J. Mikkelson United States 12 122 0.4× 160 0.6× 60 0.3× 46 0.3× 63 0.6× 15 511
Masaharu Hirata Japan 13 287 1.0× 80 0.3× 46 0.2× 109 0.6× 43 0.4× 35 514

Countries citing papers authored by Anders Buur

Since Specialization
Citations

This map shows the geographic impact of Anders Buur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Buur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Buur more than expected).

Fields of papers citing papers by Anders Buur

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anders Buur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Buur. The network helps show where Anders Buur may publish in the future.

Co-authorship network of co-authors of Anders Buur

This figure shows the co-authorship network connecting the top 25 collaborators of Anders Buur. A scholar is included among the top collaborators of Anders Buur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anders Buur. Anders Buur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Frydenvang, Karla, et al.. (2004). Assessment of the combined approach of N-alkylation and salt formation to enhance aqueous solubility of tertiary amines using bupivacaine as a model drug. European Journal of Pharmaceutical Sciences. 24(1). 85–93. 15 indexed citations
4.
Falch, Erik, Jens Perregaard, Bente Frølund, et al.. (1999). Selective Inhibitors of Glial GABA Uptake:  Synthesis, Absolute Stereochemistry, and Pharmacology of the Enantiomers of 3-Hydroxy-4-amino-4,5,6,7-tetrahydro-1,2-benzisoxazole (exo-THPO) and Analogues. Journal of Medicinal Chemistry. 42(26). 5402–5414. 37 indexed citations
5.
Buur, Anders, et al.. (1996). Permeability of 5-fluorouracil and prodrugs in Caco-2 cell monolayers. International Journal of Pharmaceutics. 129(1-2). 223–231. 28 indexed citations
6.
Buur, Anders, et al.. (1993). Prodrugs of Peptides. 18. Synthesis and Evaluation of Various Esters of Desmopressin (dDAVP). Pharmaceutical Research. 10(1). 68–74. 45 indexed citations
7.
8.
Chien, Du‐Shieng, Hitoshi Sasaki, Henning Bundgaard, Anders Buur, & Vincent H.L. Lee. (1991). Role of Enzymatic Lability in the Corneal and Conjunctival Penetration of Timolol Ester Prodrugs in the Pigmented Rabbit. Pharmaceutical Research. 8(6). 728–733. 43 indexed citations
9.
Wang, Wei, Henning Bundgaard, Anders Buur, & Vincent H.L. Lee. (1991). Corneal penetration of 5-fluorouracil and its improvement by prodrug derivatization in the albino rabbit: implication in glaucoma filtration surgery. Current Eye Research. 10(1). 87–97. 6 indexed citations
10.
Buur, Anders & Henning Bundgaard. (1989). Kinetics of the acid-catalyzed hydrolysis of cimetidine.. PubMed. 1(6). 337–42. 2 indexed citations
11.
Buur, Anders & Henning Bundgaard. (1988). Prodrugs of peptides. International Journal of Pharmaceutics. 46(1-2). 159–167. 42 indexed citations
12.
Bundgaard, Henning, et al.. (1988). Prodrugs as drug delivery systems. 77. Phthalidyl derivatives as prodrug forms for amides, sulfonamides, carbamates and other NH-acidic compounds. International Journal of Pharmaceutics. 45(1-2). 47–57. 9 indexed citations
13.
Bundgaard, Henning, et al.. (1988). Timolol prodrugs: preparation and hydrolysis kinetics of N-benzoyl carbamate esters of timolol and related compounds.. PubMed. 25(6). 293–306. 5 indexed citations
14.
Buur, Anders & Henning Bundgaard. (1987). Prodrugs of 5-fluorouracil. VIII. Improved rectal and oral delivery of 5-fluorouracil via various prodrugs. Structure-rectal absorption relationships. International Journal of Pharmaceutics. 36(1). 41–49. 24 indexed citations
15.
Bundgaard, Henning & Anders Buur. (1987). Prodrugs as drug delivery systems. 65. Hydrolysis of α-hydroxy-and α-acyloxy-N-benzoylglycine derivatives and implications for the design of prodrugs of NH-acidic compounds. International Journal of Pharmaceutics. 37(3). 185–194. 21 indexed citations
16.
Bundgaard, Henning, Anders Buur, Shih‐Chieh Chang, & Vincent H.L. Lee. (1986). Prodrugs of timolol for improved ocular delivery: synthesis, hydrolysis kinetics and lipophilicity of various timolol esters. International Journal of Pharmaceutics. 33(1-3). 15–26. 45 indexed citations
17.
Buur, Anders, Henning Bundgaard, & E. FALCH. (1986). Prodrugs of 5-fluorouracil. VII. Hydrolysis kinetics and physicochemical properties of N-ethoxy- and N-phenoxycarbonyloxymethyl derivatives of 5-fluorouracil.. PubMed. 23(4). 205–16. 12 indexed citations
18.
19.
Buur, Anders & Henning Bundgaard. (1984). Prodrugs of 5-fluorouracil. I. Hydrolysis kinetics and physicochemical properties of various N-acyl derivatives of 5-fluorouracil. International Journal of Pharmaceutics. 21(3). 349–364. 50 indexed citations
20.
Buur, Anders. (1983). Bioavailability of progesterone from rectal dosage forms in rabbits. International Journal of Pharmaceutics. 16(1). 41–46. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Staffan Tavelin Breakdown of academic impact, for papers by Balvinder S. Vig Breakdown of academic impact, for papers by I Hayakawa Breakdown of academic impact, for papers by Per Artursson Breakdown of academic impact, for papers by Sheeba Varghese Gupta Breakdown of academic impact, for papers by Tim Quach Breakdown of academic impact, for papers by Harvey Schwam Breakdown of academic impact, for papers by Doo‐Man Oh Breakdown of academic impact, for papers by Thomas J. Mikkelson Breakdown of academic impact, for papers by Masaharu Hirata
Rankless by CCL
2026